SATO Welcomes New ISB Standard for Patient Identification

GS1 Solutions Partner, SATO UK, a subsidiary of the barcode and RFID technology company, SATO Holdings Corporation, has welcomed the recent publication of the Information Standards Board (ISB) for Health and Social Care Standard 1077, which will see every patient in England given a wristband with a barcode to ensure enhanced patient management.

The new standard defines how to encode the NHS approved patient identifiers for identity bands and bracelets into a 2D GS1 DataMatrix barcode, and from April 2012, all National Health Trusts must have plans to ensure that their systems are in line with the new guidelines which take effect on 1st October 2013.

Having recently received certification for its newly developed patient wristband identification system from GS1, the global organisation responsible for developing and administering barcode identification standards worldwide, SATO's European Managing Director, Brian Lang commented on the new ISB Standard: "As a company that is involved in providing identification solutions to the healthcare industry in the UK, we obviously welcome the introduction of the ISB standard 1077 as it presents the opportunity to improve patient care through the use of advanced technology, making healthcare facilities as safe and error-free as possible.

"SATO has been involved in the development of straightforward, yet fail-safe systems of positive patient identification for many years, working with individual hospitals to produce solutions which suit their specific requirements. Electronic bar code technology provides a greater volume of key data at the bedside, and this new standard will ensure the right care is given to the right patient, at the right time."

SATO has developed a system for patient identification wristbands that incorporates SATO's compact and versatile CG2 barcode printer, SATO LabelGallery software and the company's existing range of patient identification wristbands. The complete system has been approved as suitable for use in UK hospitals and patient healthcare facilities by GS1.

SATO's new patient wristband identification system, which meets the required standard for 2D barcode print quality, was approved by GS1 following stringent tests to determine its conformance to the specific patient information structure required for patient identification wristbands.

About SATO
SATO is a pioneer and leading global provider of integrated Automatic Identification and Data Collection solutions that leverage barcode and RFID technologies. SATO manufactures innovative, reliable auto-identification systems and offers complete solutions to businesses by integrating hardware, software, media supplies and maintenance services. Customers rely on SATO for accuracy, labour and resource savings helping to preserve the environment.

Founded in 1940, SATO is publicly listed on the first section of Tokyo Stock Exchange in Japan. It has sales and support offices in over 20 countries and is represented globally through a world-class network of partners. For the fiscal year ended March 31, 2011, it reported revenues of JPY 78,368 million (US$ 914 million).

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...